Samir Narayan

5.8k total citations · 2 hit papers
59 papers, 2.6k citations indexed

About

Samir Narayan is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiation. According to data from OpenAlex, Samir Narayan has authored 59 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pulmonary and Respiratory Medicine, 22 papers in Oncology and 18 papers in Radiation. Recurrent topics in Samir Narayan's work include Lung Cancer Diagnosis and Treatment (19 papers), Advanced Radiotherapy Techniques (18 papers) and Lung Cancer Treatments and Mutations (14 papers). Samir Narayan is often cited by papers focused on Lung Cancer Diagnosis and Treatment (19 papers), Advanced Radiotherapy Techniques (18 papers) and Lung Cancer Treatments and Mutations (14 papers). Samir Narayan collaborates with scholars based in United States, Canada and India. Samir Narayan's co-authors include Srinivasan Vijayakumar, William H. Hall, Ashesh B. Jani, R. Ramanathan, Vivek S. Kavadi, Jeffrey D. Bradley, Rebecca Paulus, Chen Hu, Clifford G. Robinson and Jeffrey A. Bogart and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Clinical Cancer Research.

In The Last Decade

Samir Narayan

56 papers receiving 2.6k citations

Hit Papers

Impact of Intensity-Modulated Radiation Therapy Technique... 2016 2026 2019 2022 2016 2019 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non–Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial
    2016 528 citations Stephen G. Chun, Chen Hu et al. Journal of Clinical Oncology profile →
  2. Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non–Small-Cell Lung Cancer
    2019 352 citations Jeffrey D. Bradley, Chen Hu et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samir Narayan United States 24 1.7k 761 723 619 507 59 2.6k
Brent S. Rose United States 28 1.2k 0.7× 807 1.1× 412 0.6× 424 0.7× 766 1.5× 171 2.6k
Nam P. Nguyen United States 30 1.8k 1.1× 807 1.1× 556 0.8× 529 0.9× 1.0k 2.0× 165 4.0k
Nitin Ohri United States 28 1.2k 0.7× 1.1k 1.5× 649 0.9× 970 1.6× 437 0.9× 142 3.1k
John A. Howington United States 21 2.2k 1.3× 648 0.9× 166 0.2× 472 0.8× 749 1.5× 50 2.8k
Gerben Bootsma Netherlands 26 1.6k 0.9× 821 1.1× 407 0.6× 689 1.1× 169 0.3× 65 2.1k
John Kim Canada 27 815 0.5× 773 1.0× 487 0.7× 368 0.6× 801 1.6× 66 2.6k
Richard L. Cumberlin United States 8 893 0.5× 857 1.1× 281 0.4× 307 0.5× 529 1.0× 14 2.3k
Juan P. Wisnivesky United States 32 2.4k 1.4× 675 0.9× 109 0.2× 482 0.8× 484 1.0× 82 3.0k
Walter J. Scott United States 30 2.8k 1.7× 603 0.8× 147 0.2× 812 1.3× 1.6k 3.2× 78 4.0k
Jan Festen Netherlands 20 1.6k 0.9× 814 1.1× 230 0.3× 175 0.3× 242 0.5× 53 2.2k

Countries citing papers authored by Samir Narayan

Since Specialization
Citations

This map shows the geographic impact of Samir Narayan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samir Narayan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samir Narayan more than expected).

Fields of papers citing papers by Samir Narayan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samir Narayan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samir Narayan. The network helps show where Samir Narayan may publish in the future.

Co-authorship network of co-authors of Samir Narayan

This figure shows the co-authorship network connecting the top 25 collaborators of Samir Narayan. A scholar is included among the top collaborators of Samir Narayan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samir Narayan. Samir Narayan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Narayan, Samir, et al.. (2025). The Effect of Kinesio Taping After Impacted Third Molar Surgery: A Randomized Control Trial. Journal of Maxillofacial and Oral Surgery. 24(5). 1468–1473. 1 indexed citations
2.
Chun, Stephen G., Chen Hu, Ritsuko Komaki, et al.. (2024). Long-Term Prospective Outcomes of Intensity Modulated Radiotherapy for Locally Advanced Lung Cancer. JAMA Oncology. 10(8). 1111–1111. 10 indexed citations
3.
Weidhaas, Joanne B., Chen Hu, Ritsuko Komaki, et al.. (2023). The Inherited KRAS -variant as a Biomarker of Cetuximab Response in NSCLC. Cancer Research Communications. 3(10). 2074–2081. 1 indexed citations
4.
5.
Thor, Maria, Joseph O. Deasy, Chen Hu, et al.. (2020). Modeling the Impact of Cardiopulmonary Irradiation on Overall Survival in NRG Oncology Trial RTOG 0617. Clinical Cancer Research. 26(17). 4643–4650. 45 indexed citations
6.
Kong, Feng‐Ming, Chen Hu, Weili Wang, et al.. (2020). RTOG0617 to Externally Validate Blood Cell ERCC1/2 Genotypic Signature as a Radiosensitivity Biomarker for Both Tumor and Normal Tissue for Individualized Dose Prescription. International Journal of Radiation Oncology*Biology*Physics. 108(3). S2–S2. 3 indexed citations
7.
Olsen, Jeffrey R., Jennifer Moughan, Robert J. Myerson, et al.. (2017). Predictors of Radiation Therapy–Related Gastrointestinal Toxicity From Anal Cancer Dose-Painted Intensity Modulated Radiation Therapy: Secondary Analysis of NRG Oncology RTOG 0529. International Journal of Radiation Oncology*Biology*Physics. 98(2). 400–408. 36 indexed citations
8.
Ben‐Josef, Edgar, William F. Regine, Ross A. Abrams, et al.. (2015). Glycogen Synthase Kinase 3 Beta Predicts Survival in Resected Adenocarcinoma of the Pancreas. Clinical Cancer Research. 21(24). 5612–5618. 5 indexed citations
9.
Chun, Stephen G., Chen Hu, H. Choy, et al.. (2015). Comparison of 3-D Conformal and Intensity Modulated Radiation Therapy Outcomes for Locally Advanced Non-Small Cell Lung Cancer in NRG Oncology/RTOG 0617. International Journal of Radiation Oncology*Biology*Physics. 93(3). S1–S2. 24 indexed citations
10.
11.
Kapoor, Akhil, et al.. (2015). Allele Frequency of Abo and Rh Blood Group and the Risk of Non Small Cell Lung Carcinoma. Annals of Oncology. 26. i1–i1.
12.
Krauss, Daniel, Chen Hu, Jean-Paul Bahary, et al.. (2015). Importance of Local Control in Early-Stage Prostate Cancer: Outcomes of Patients With Positive Post-Radiation Therapy Biopsy Results Treated in RTOG 9408. International Journal of Radiation Oncology*Biology*Physics. 92(4). 863–873. 22 indexed citations
13.
Olsen, Jeffrey R., Jennifer Moughan, Robert J. Myerson, et al.. (2014). Predictors of Radiotherapy-Related GI Toxicity from Anal Cancer DP-IMRT: Secondary Analysis of RTOG 0529. International Journal of Radiation Oncology*Biology*Physics. 90(1). S31–S31. 1 indexed citations
14.
Singhal, Mukesh, Samir Narayan, Deepti Singh, et al.. (2014). A Phase III Trial Comparing Folfirinox Versus Gemcitabine for Metastatic Pancreatic Cancer. Annals of Oncology. 25. iv210–iv210. 16 indexed citations
15.
Bradley, Jeffrey D., Rebecca Paulus, Ritsuko Komaki, et al.. (2013). A randomized phase III comparison of standard-dose (60 Gy) versus high-dose (74 Gy) conformal chemoradiotherapy with or without cetuximab for stage III non-small cell lung cancer: Results on radiation dose in RTOG 0617.. Journal of Clinical Oncology. 31(15_suppl). 7501–7501. 112 indexed citations
16.
Narayan, Samir, Jöerg Lehmann, Matthew A. Coleman, et al.. (2008). Prospective Evaluation to Establish a Dose Response for Clinical Oral Mucositis in Patients Undergoing Head-and-Neck Conformal Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 72(3). 756–762.e4. 55 indexed citations
17.
Luo, Chunhui, Claus Chunli Yang, Samir Narayan, et al.. (2006). Use of benchmark dose–volume histograms for selection of the optimal technique between three-dimensional conformal radiation therapy and intensity-modulated radiation therapy in prostate cancer. International Journal of Radiation Oncology*Biology*Physics. 66(4). 1253–1262. 23 indexed citations
18.
Narayan, Samir & Charles R. Thomas. (2006). Multimodality therapy for Pancoast tumor. Nature Clinical Practice Oncology. 3(9). 484–491. 10 indexed citations
19.
Narayan, Samir. (2005). The use of intensity-modulated radiation therapy in the treatment of oropharyngeal carcinoma. Current Opinion in Otolaryngology & Head & Neck Surgery. 13(4). 226–232. 4 indexed citations
20.
Narayan, Samir, Wayne T. Cornblath, Howard M. Sandler, Victor M. Elner, & James A. Hayman. (2003). Preliminary visual outcomes after three-dimensional conformal radiation therapy for optic nerve sheath meningioma. International Journal of Radiation Oncology*Biology*Physics. 56(2). 537–543. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brent S. Rose Breakdown of academic impact, for papers by Nam P. Nguyen Breakdown of academic impact, for papers by Nitin Ohri Breakdown of academic impact, for papers by John A. Howington Breakdown of academic impact, for papers by Gerben Bootsma Breakdown of academic impact, for papers by John Kim Breakdown of academic impact, for papers by Richard L. Cumberlin Breakdown of academic impact, for papers by Juan P. Wisnivesky Breakdown of academic impact, for papers by Walter J. Scott Breakdown of academic impact, for papers by Jan Festen
Rankless by CCL
2026